Evernow’s menopause membership, judged plainly
Evernow runs a virtual menopause practice for perimenopause and the years after it: a symptom-led intake, clinicians who can prescribe hormone therapy, and an iOS app that carries messaging, plan changes and refills. The recurring charge sits at the low end for telehealth at $35 a month, with one caveat that has to travel beside it: meds billed separately. That structure suits someone who wants a hormone plan adjusted over months rather than a single consultation, and it will frustrate anyone who wants one all-in number covering care and drugs together. Insurance billing is offered alongside a cash-pay route, which is less common in this corner of telemedicine and can take real money off the total. The soft spot is patient evidence: the pool of public Evernow reviews is small, so the sentiment signal reads as thin rather than good or bad.
What the monthly fee buys, and what bills separately
The entry point is $35 a month, and the qualifier is simple: meds billed separately. The fee buys the care relationship. That means the intake, a treatment plan from a clinician who works in menopause, messaging inside the app, and changes to the prescription when a dose or a route is not working. It does not buy the medicine. An estradiol patch, a progesterone capsule or a vaginal cream is dispensed by a pharmacy and charged by that pharmacy.
So budget on two lines rather than one. Line one is the membership, which is predictable. Line two is the drug, which is not. What you pay there depends on the exact product, the pharmacy that fills it, and whether a plan is paying part of it. Generic estradiol and generic micronized progesterone are widely stocked, which usually helps; brand-name products paid in cash usually do not.
Ask for the drug name, strength and quantity written on the prescription, then price that at your own pharmacy before the first fill. It is the single fastest way to turn a vague monthly guess into a real number.
Both payment routes exist here. Billing insurance can reduce the visit cost, though what you owe still depends on your copay and deductible. Cash pay means the membership plus the full pharmacy charge, with no claim filed. Neither route is automatically the cheaper one, and the answer changes with your plan and your prescription.
If you are weighing coverage against paying cash for both the visit and the medicine, run that comparison before you enrol.
Insurance or cash pay, which is cheaper
Going through insurance is not automatically cheaper. Deductibles, copays and prior authorisation can make a cash-pay programme the better deal.
Coverage is never something a programme can promise: plans decide, prior authorisation is routine for GLP-1 medicines, and denials are common. Confirm with your own plan before choosing.
Cancellation terms deserve the same attention as the joining price. Message support inside the app so you have a written record, and ask three things: how much notice a cancellation needs, whether the month in progress is refundable, and what happens to an open prescription and its remaining refills once you stop paying. Ask too whether any visit type carries a separate consultation charge on top of the recurring fee, because menopause telehealth pricing in this category shifts between membership and per visit models. Our free savings report shows how a care fee and a pharmacy bill add up together.
How the practice decides what to prescribe
Menopause is normally diagnosed from symptoms and cycle history rather than a lab result. In women over 45 with typical symptoms, hormone blood tests swing too much during perimenopause to be reliable, which is why guidance leans on the clinical picture, as the National Institute on Aging sets out in its patient guide to menopause. A symptom-led intake is therefore the correct starting point, not a shortcut.
Expect the intake to cover hot flashes, night sweats, sleep, mood, brain fog, palpitations, joint aches, vaginal dryness and pain with sex. Expect it also to dig into history that changes the safety calculation: blood clots, stroke or heart attack, breast or endometrial cancer, unexplained vaginal bleeding, migraine with aura, liver disease, blood pressure and smoking. Answer those questions carefully. They are what stands between you and a prescription you should not be taking.
Prescriber contact runs through the app rather than a scheduled phone tree, so it helps to know how the practice paces follow-up. Ask when someone will check the first dose, how often reviews happen after that, and who answers if a symptom changes between reviews. Hormone therapy is a titration exercise: the first dose is a starting point, and the useful dose is often found on the second or third pass.
Two practical limits are worth naming now. Routine hormone level testing is not needed to make the diagnosis in most patients, so do not expect a lab panel to be the centrepiece. And physical care stays local. Pelvic and breast exams, mammography, bone density scanning and cervical screening cannot be delivered down a video link, so keep a local clinician in the picture. Our medication index is a useful place to read up on a drug before your visit.
Systemic estrogen: patches, gels, sprays and tablets
What it treats and how well
Systemic estrogen is the most effective treatment for moderate to severe hot flashes and night sweats, and it also helps sleep disruption driven by those symptoms. It is prescribed for vasomotor symptoms, for genitourinary symptoms, and in some cases for prevention of bone loss. The American College of Obstetricians and Gynecologists summarises the benefit and risk picture in its hormone therapy patient FAQ.
Why the route matters
Oral estradiol passes through the liver first. Transdermal forms, meaning patches, gels and sprays, do not, and observational evidence has linked transdermal delivery with a lower risk of blood clots than tablets. That is why a clinician may steer someone with migraine, higher clot risk, or certain metabolic factors toward a patch. Patches are changed on a schedule rather than taken daily; gels and sprays are applied daily to clean dry skin and need drying time before contact with anyone else.
Warnings, contraindications and monitoring
These are prescription drugs with real label warnings. The FDA’s information on estrogen and estrogen plus progestin therapies covers the class risks: endometrial cancer when estrogen is used without a progestogen in someone with a uterus, cardiovascular events, stroke, blood clots, and an increased breast cancer risk seen with combined therapy in the Women’s Health Initiative trials, summarised by the NHLBI research programme. Labelling in this area has been under active FDA review, so read the current Medication Guide dispensed with your prescription rather than an older summary.
Estrogen is generally not used with known or suspected breast cancer, estrogen-dependent cancer, undiagnosed abnormal genital bleeding, active or past blood clots or arterial thromboembolic disease, liver problems, known thrombophilia, or in pregnancy. Common side effects include breast tenderness, headache, nausea, spotting and skin reactions at a patch site. Monitoring worth agreeing upfront: blood pressure, breast screening on the normal local schedule, and prompt reporting of any new vaginal bleeding, calf swelling, chest pain, severe headache or sudden vision change.
What it costs through this practice
The membership is one charge and the pharmacy fill is another. Generic estradiol patches and tablets are commonly stocked and are often the least expensive route, but the exact figure depends on the pharmacy and your coverage, so confirm it before the script is sent.
Who it suits
Best fit is someone in the menopause transition or the early postmenopausal years with disruptive hot flashes and no contraindication, who wants a clinician available to adjust the dose over several months rather than once.
Progesterone, and why a uterus changes the prescription
If you still have a uterus, estrogen alone thickens the endometrium and raises the risk of endometrial cancer over time. A progestogen is added to protect the lining, most often micronized progesterone, either daily or on a cyclical schedule. If you have had a hysterectomy, estrogen is usually prescribed on its own.
Micronized progesterone is commonly taken at bedtime because it can cause drowsiness, and some patients find that side effect useful for sleep. Other reported effects include dizziness, breast tenderness, bloating and mood change. It is derived from peanut oil in some formulations, which matters if you have a peanut allergy, so flag that at intake.
Two things to confirm with the prescriber: whether your regimen is continuous or cyclical, and what bleeding pattern is expected on it. Unscheduled bleeding after the first few months is a reason to be assessed rather than to wait it out, and that assessment usually needs an in-person examination or an ultrasound.
Vaginal estrogen for dryness, painful sex and urinary symptoms
Genitourinary syndrome of menopause is the cluster of vaginal dryness, burning, pain with sex, urinary urgency and recurrent urinary tract infections that comes from falling estrogen in local tissue. It rarely improves on its own, and unlike hot flashes it tends to get worse with time.
Low-dose vaginal estrogen is delivered as a cream, a tablet or insert, or a ring. Absorption into the bloodstream is low at these doses, which is why local therapy is often used when systemic hormones are unsuitable, and why a progestogen is generally not required for endometrial protection with low-dose local products. The class labelling still carries the estrogen warnings, so the risk conversation belongs with your prescriber rather than with a marketing page. MedlinePlus gives a plain-language overview of the therapy classes.
Non-prescription vaginal moisturisers and lubricants are a reasonable first step for mild symptoms and can be used alongside prescription treatment. If pain with sex persists on local estrogen, say so at follow-up: dosing frequency is often adjusted after the first weeks, and persistent pain sometimes needs a physical examination that telehealth cannot perform.
Non-hormonal routes when estrogen is off the table
Some patients cannot take estrogen, and some simply do not want to. Prescription non-hormonal options for hot flashes exist. A low-dose form of paroxetine is FDA approved for moderate to severe vasomotor symptoms; other SSRIs and SNRIs, plus gabapentin and clonidine, are used off label with varying evidence. A newer neurokinin receptor antagonist class is also approved for hot flashes, and the FDA has warned about rare but serious liver injury with fezolinetant, which is why baseline and periodic liver blood tests are part of that label. The agency’s drug safety communications are the place to check current wording.
Ask directly at intake which of these the clinicians here will prescribe, because a practice built around hormone therapy is not obliged to carry every alternative. If the answer is limited, that is not a defect; it is a reason to keep a local prescriber involved. Behaviour change helps at the margins too: layered clothing, a cool bedroom, limiting alcohol and managing weight all reduce symptom load for some patients, and cognitive behavioural therapy has evidence for the distress that hot flashes cause. Our editorial coverage goes deeper on how these choices are usually sequenced.
Testosterone: what to expect if you ask
This is one of the most searched questions about virtual menopause care, so here is the flat answer. There is currently no testosterone product approved by the FDA for use in women in the United States. When testosterone is prescribed to a woman, it is off label, usually at a small fraction of a male dose, and the strongest supporting evidence is for low sexual desire that causes distress after menopause, not for fatigue, mood or body composition.
If testosterone matters to you, ask before you pay: do the clinicians here prescribe it, from which pharmacy is it dispensed, what blood level monitoring do they require, and how often. Ask also about side effects to watch for, including acne, unwanted hair growth and voice change, some of which do not fully reverse. A practice that declines to prescribe it is following a conservative reading of the approvals rather than withholding care.
Bioidentical and compounded hormones: reading the label claim
The word bioidentical does more marketing work than clinical work. Many FDA-approved products, including estradiol and micronized progesterone, are chemically identical to the hormones the body makes. So a bioidentical prescription is not automatically a compounded one, and a compounded one is not automatically better.
The distinction that matters is regulatory. FDA-approved products are made to a tested standard with an approved label. Compounded preparations are mixed for an individual patient and are not FDA approved, meaning they are not reviewed for safety, effectiveness or manufacturing quality in the same way, as the agency explains in its compounding questions and answers. Claims that compounded hormone therapy is safer than approved therapy are not supported by the evidence base.
So ask a specific question rather than a general one: is my prescription an FDA-approved product, and if it is compounded, which pharmacy makes it and why was that route chosen for me? Pellet therapy in particular deserves scepticism, since dosing cannot be adjusted or withdrawn once implanted.
How the treatment tracks compare on care, not price
| Track | What it targets | How it is taken | Monitoring worth agreeing |
|---|---|---|---|
| Systemic estrogen | Hot flashes, night sweats, sleep disruption, bone loss | Patch, gel, spray or daily tablet | Blood pressure, symptom review, any new bleeding reported |
| Progestogen | Endometrial protection alongside systemic estrogen | Nightly or cyclical capsule | Bleeding pattern, drowsiness, whether the schedule suits you |
| Vaginal estrogen | Dryness, pain with sex, urinary urgency, recurrent UTIs | Cream, tablet or insert, or ring | Response at several weeks, dosing frequency, persistent pain |
| Non-hormonal prescriptions | Hot flashes when estrogen is unsuitable or unwanted | Daily oral medicine | Drug-specific checks, including liver tests for some agents |
Treatment Tracks at a Glance
| What It Targets | Monitoring to Agree Upfront | |
|---|---|---|
| Systemic estrogen | Hot flashes, night sweats, sleep, bone loss | Blood pressure, symptom review, any new bleeding |
| Progestogen | Endometrial protection alongside systemic estrogen | Bleeding pattern, drowsiness, schedule fit |
| Vaginal estrogen | Dryness, pain with sex, urinary urgency, recurrent UTIs | Response at several weeks, dosing frequency, persistent pain |
| Non-hormonal prescriptions | Hot flashes when estrogen is unsuitable or unwanted | Drug-specific checks, liver tests for some agents |
Signing up, the app, and how leaving works
Step 1: check where you can be treated
Virtual prescribing depends on the state you are physically in during the visit. Confirm that the clinicians are licensed where you live before you pay anything, and tell them if you split time between two states.
Step 2: complete the symptom intake
Expect a structured questionnaire covering symptoms, cycle history, medical and family history, current medicines and supplements. Have your blood pressure and a list of your prescriptions to hand.
Step 3: start the membership
The recurring charge begins the care relationship. Screenshot what you are agreeing to, including the billing date and any trial or introductory terms, so you can hold the practice to it later.
Step 4: review the plan with a clinician
This is where the route is chosen: transdermal or oral, whether a progestogen is needed, whether local estrogen goes alongside it. Ask why this option and not another, and what the fallback is if it does not work.
Step 5: fill the prescription and set a follow-up
The script goes to a pharmacy, which bills you separately. Before you close the app, note the date you will report back on how the dose is working.
The app itself is published as Evernow: Menopause Care on the Apple App Store, and it functions as the portal for messaging, plan changes and refill requests. If you are an Android user, or you prefer to work in a browser, confirm what the web login gives you before you commit. Cancellation should be handled the same way as everything else, in writing inside the app, and the confirmation is worth keeping. Ease of leaving is part of what a subscription is worth.
Support, refills and pharmacy handoffs
Support here is asynchronous by design. Messaging replaces phone queues, which suits most menopause questions well, since dose tweaks and side effect reports do not need a same-hour answer. It suits urgent problems less well, so ask what the practice tells patients to do about heavy bleeding, chest pain, calf swelling or a severe headache, and make sure the answer routes you to urgent care rather than a message queue.
Refill reliability is the part patients feel most. Ask how many refills a prescription carries, how far ahead a renewal request should go in, and whether a follow-up is required before the next authorisation. Then ask a mechanical question: how is the prescription transmitted to your pharmacy? We could not find this practice in the Surescripts e-prescribing directory, so it is worth confirming that your chosen pharmacy receives scripts from them cleanly, particularly if you use a small independent or a mail-order plan pharmacy.
One more escalation question that patients forget: if your local gynaecologist or primary care doctor needs the notes, how do you get a copy of your record, and how long does that take?
Privacy: what to check before you upload your symptom history
Menopause intake data is intimate. It covers bleeding, sex, mood and mental health. The clinical care itself sits under HIPAA, which sets rules on how protected health information is used and shared, explained in plain terms by HHS guidance for individuals. What often sits outside that protection is the consumer app layer: marketing analytics, advertising identifiers and website trackers.
Read the privacy policy for four specific things rather than skimming it. What categories of data are collected beyond your medical record. Whether any of it is shared with advertising or analytics partners. Whether you can delete your account and your data, and what is retained regardless because it forms part of a medical record. And whether the app requests permissions it does not obviously need. If a policy is vague on sharing, ask support in writing for a clear answer before your intake, not after.
The trust and safety record
On the checks that can be verified from outside, this one holds up reasonably well. The operation is LegitScript certified, a monitoring programme that reviews healthcare merchants against legal and regulatory standards and that you can confirm through the LegitScript certification lookup. We found no FDA warning letter naming the company in the public enforcement record, which is the single most useful negative signal in telehealth and its absence is worth something.
Transparency is split. The recurring membership is stated clearly and is easy to compare against other menopause services. Medication cost is the opaque half, because it depends on the pharmacy and the plan, and that gap is exactly where patients get surprised. The absence of a Surescripts directory entry is not a red flag on its own; plenty of practices prescribe through other systems. It is simply one fewer public confirmation, which is why the pharmacy question above matters.
For clarity on our side: prices here are desk-verified against the provider’s live site and re-checked monthly, community reviews on this site are moderated rather than verified, and any sponsored placement is labelled and never changes a score. You can read the full weighting in how we score providers.
Insurance, coverage and the care that stays local
The ability to bill insurance is a genuine differentiator in menopause telemedicine, where cash-only models are common. It does not guarantee your plan will pay, and it does not cover the pharmacy side automatically. Your drug cost runs through your pharmacy benefit, which is a separate determination from the visit. If you are 65 or older, hormone therapy is typically handled under a Part D plan, and the rules and formularies are set out at Medicare.gov.
Access has hard edges too. This is a prescribing and monitoring service, not a full women’s health clinic. Pelvic examinations, mammograms, bone density scans, cervical screening and any ultrasound for abnormal bleeding all require an in-person clinician. Treat the membership as an addition to local care rather than a replacement for it, and make sure someone locally holds the whole picture.
The patients this fits, and the ones it will frustrate
Good fit: someone with clear vasomotor or genitourinary symptoms who wants a clinician focused on menopause, who is comfortable with asynchronous messaging, and who values a low recurring care fee with the flexibility to adjust treatment over several months. Also a good fit if your local practice has been dismissive, which remains a common reason patients look for virtual menopause care in the first place.
Poor fit: anyone who wants a single bundled monthly figure covering care plus medicine, anyone who needs a physical examination soon, anyone with a complex history involving hormone-sensitive cancer or clotting disorders that really belongs with a specialist in person, and anyone who wants a large body of patient feedback to read before they commit. If you are still weighing services, our telehealth provider directory is the wider field.
Questions to Ask Before Your First Visit
- Which states are your clinicians licensed in?
- How soon after starting will someone review my dose?
- Is my prescription FDA-approved or compounded, and which pharmacy fills it?
- What is the cancellation notice period, and is the current month refundable?
- What happens to remaining refills if I stop the membership?
- How do I get a copy of my records for my local doctor?
What to ask before your first visit
- Which states are your clinicians licensed in, and who will I actually be seeing?
- How soon after I start will someone review the dose, and how often after that?
- Is my prescription an FDA-approved product or a compounded preparation, and which pharmacy fills it?
- What is your notice period for cancellation, and is the current month refundable?
- What happens to my remaining refills if I stop the membership?
- How do I get a copy of my records for my local doctor?
If you are switching from another service, ask your current one the same questions in reverse: how records transfer, whether an existing prescription can be continued without a gap, and when a cancellation takes effect relative to the next billing date. Line the two dates up so you do not pay twice in one month.
Before you commit, it is worth seeing what a year of membership plus pharmacy fills actually totals. Run my numbers, then compare that against what you would pay locally.
What a year actually costs
Programmes quote a monthly headline. Add the medication, the labs and the renewal price and the real number is usually different.
Advertised prices change often and intro pricing rarely lasts. Ask what the renewal rate is before you commit to a plan.
Our cost calculators cover the rest of the arithmetic.
Reputation check: what the public record shows
Public sentiment is thin rather than hostile. The Trustpilot business profile for evernow.com carries only a handful of contributors, which is too small a sample to read as a trend in either direction, and small samples move sharply on a single unhappy customer. Treat it as background, not evidence.
The iOS app is published as Evernow: Menopause Care on the Apple App Store, where you can check the current rating and the most recent reviews yourself before you download it. App store comments tend to surface billing and messaging friction faster than clinical detail, so read them for how the service behaves day to day.
Community discussion sits mainly in the r/Menopause subreddit, where threads about virtual menopause care return to the same trade-off: convenience and a clinician who takes the symptoms seriously, weighed against paying out of pocket. Forum posts are anecdote, not evidence, and they are not a substitute for the questions above. On the corporate side, Fierce Healthcare reported a 28.5 million dollar Series A in April 2022 to expand virtual menopause treatment. Funding says something about resources behind the operation and nothing at all about the quality of your care. Taken together, the available Evernow reviews justify neither enthusiasm nor alarm, which is why the verifiable items, LegitScript status, the clean FDA record and the written cancellation terms, should carry more weight in your decision than the crowd.
Educational content, not medical advice. Always consult a qualified clinician before starting, stopping or switching treatment.